BIO-Europe® 2025: Vienna Prepares to Welcome Global Biopharma Leaders [Yahoo! Finance]
Ovid Therapeutics Inc. (OVID)
Last ovid therapeutics inc. earnings: 3/11 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.ovidrx.com
Company Research
Source: Yahoo! Finance
conference for the global biopharmaceutical industry, which will take place in Vienna, Austria, from November 3 - 5, 2025 . More than 5,700 attendees from 3,000+ companies, including leading pharma firms, innovative biotechs, and global investors, will gather in one of Europe's most dynamic hubs for science and biopharma innovation. Partnering officially opened on September 22 and is now in full swing. Over 30,000 one-to-one meetings are expected in total, emphasizing BIO-Europe's role as the leading forum for dealmaking and collaboration across the industry. Key Sessions and Events at BIO-Europe 2025 The 31 st annual BIO-Europe program , curated by EBD Group, strikes a balance between engaging content, high-impact partnering, and extensive networking opportunities. Inspired by Vienna's renowned musical heritage and vibrant coffeehouse culture, the agenda combines thought-provoking discussions with opportunities to connect and collaborate. Highlights include: Opening Plenary –
Show less
Read more
Impact Snapshot
Event Time:
OVID
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OVID alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OVID alerts
High impacting Ovid Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
OVID
News
- Ovid Therapeutics Appoints Dr. Petra Kaufmann as Chief Medical OfficerGlobeNewswire
- Ovid Therapeutics (NASDAQ:OVID) had its "buy" rating reaffirmed by analysts at HC Wainwright.MarketBeat
- Ovid Therapeutics (NASDAQ:OVID) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.MarketBeat
- Ovid Therapeutics (NASDAQ:OVID) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $5.00 price target on the stock.MarketBeat
- Ovid Therapeutics (OVID) Reports Q3 Loss, Lags Revenue Estimates [Yahoo! Finance]Yahoo! Finance
OVID
Earnings
- 11/12/25 - Miss
OVID
Sec Filings
- 11/12/25 - Form 10-Q
- 11/12/25 - Form 8-K
- 11/7/25 - Form DEF
- OVID's page on the SEC website